Trial Profile
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Paclitaxel (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RIBS-IV
- 01 May 2021 Results of pooled analysis from ribs IV and V studies assessing influence of neoatherosclerosis on the prognosis and response to treatment of patients with SR published in the Revista Espanola de Cardiologia
- 05 Jan 2017 Results (n=249) of pooled analysis of RIBS IV and RIBS V studies assessing the safety and efficacy of DEB in patients with ISR, published in the American Journal of Cardiology
- 08 Dec 2015 Results (pooled analysis of RIBS IV and RIBS V trials) published in the American Journal of Cardiology (n = 442).